22nd Century Group Inc (XXII)

[Giovanni]

ROFLMAO Medical Cannabis Technology News:

CanBreed, an Israeli Cannabis genetics and seeds company, says it has used genome editing technology to make the plant resistant to Powdery Mildew, a type of fungus that can be deadly for cannabis. Courtesy
This article was first published by The Times of Israel and is re-posted with permission.

Israeli startup CanBreed said it has used gene editing technology to alter a gene in the cannabis plant to make the plant resistant to powdery mildew, a fungus that can be deadly for the plant.



CanBreed said that to the best of its knowledge, this is the first time a commercial company has managed to perform genome editing on a cannabis plant. The editing was done using CRISPR-Cas9 gene editing technology.

SEE ALSO: GemmaCert Analyzes Cannabis Potency In Minutes, Using Machine Learning And Advanced Imaging Tech

CanBreed's R&D work using genome editing technology has shown that the plant coud be made resistant to Powdery Mildew, a type of fungus that can be deadly for cannabis. Courtesy

It is very hard” to use the CRISPR technology on the cannabis plant, said Ido Margalit, CanBreed’s CEO, in a phone interview. Through the use of the technology, the startup’s R&D team, composed of geneticists, molecular biologists and agronomists, edited a gene that expresses a protein responsible for creating sensitivity to powdery mildew infection, he said.

To read the full article, click here.

Related articles

Israeli Researchers Say Medical Cannabis Could Effectively Treat Some COVID-19 Symptoms
Israeli Researchers Tout ‘1st Clinical Evidence’ That Controlled Doses Of Cannabis Relieve Pain


FACEBOOK COMMENTS